BPA CALL
Active75F40126F19011
Department of Health and Human Services › Food and Drug Administration › FDA OFFICE OF ACQ GRANT SVCS
$11.3M
obligated · signed 3 weeks ago
EO 14398
Performance timeline
Start
Sep 20, 2026
Current end
Sep 19, 2027
Potential end
Sep 19, 2028
with all options
Loading status
Estimated start: Sep 19, 2027
DELOITTE CONSULTING LLP
Contract 75F40126F19011
UEI
CKV2L9GZKJK3
Parent Company
DELOITTE CONSULTING LLP
Capabilities & Certifications
Headquarters Location
Congressional District: 08
Current Obligation
$11,316,218
Base + Exercised Options
$11,316,218
Total Ceiling Value
$19,761,293
Contract Type
FIRM FIXED PRICE
NAICS
ALL OTHER PROFESSIONAL, SCIENTIFIC, AND TECHNICAL SERVICES
PSC
SPECIAL STUDIES/ANALYSIS- REGULATORY
Place of Performance
Congressional District: 04
Awarding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Funding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Contract Vehicle
75F40122A00018
BPADepartment of Health and Human Services
Award type: SINGLE AWARD
Solicitation procedures, competition exceptions, labor standards and account totals.